AltPep announces closing $23.150 million Series A investment round, let by Matrix Capital Management with significant participation by Alexandria Venture Investments. In conjunction with the financing, David Goel, Managing General Partner and Co-founder of Matrix...
Chad is the co-founder and CEO of Adaptive Biotechnologies, a commercial-stage biotech company in Seattle that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease.
Recent Comments